Rep. Jim Langevin (D-R.I.) has voiced support for the Food and Drug Administration‘s draft guidance for manufacturers to protect medical technology products against cybersecurity threats.
Langevin, co-chair of the Congressional Cybersecurity Caucus, said Thursday he believes the guidance FDA issued in January can serve as a tool for the safe implementation of networked medical devices.
“It is critical that medical device manufacturers do everything possible to address vulnerabilities and protect patients, and I applaud the FDA for tackling a complex challenge that will affect the health care industry now and well into the future,” he noted.
“I look forward to continuing to work with agencies to develop strategies to address cyber safety issues.”
FDA released a set of medical device cybersecurity guidelines earlier this year in an effort to help vendors manage threats through a risk-based strategy.
